Tech Company Financing Transactions
Biological Dynamics Funding Round
On 11/9/2015, Biological Dynamics landed $26.8 million in Series C funding from Alexandria Venture Investments, Heritage Group and private investors.
Transaction Overview
Company Name
Announced On
11/9/2015
Transaction Type
Venture Equity
Amount
$26,800,000
Round
Series C
Investors
Proceeds Purpose
Proceeds from the financing will be used to advance regulatory clearance for the company's lead oncology diagnostic program, TR(ACE)� assay, and for general working capital purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9393 Towne Centre Dr. 140
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Biological Dynamics is a private molecular diagnostics company located in San Diego. CA. Our proprietary lab-on-chip ACE platform offers a rapid and affordable way to isolate nanoparticles directly from physiological solutions, such as whole blood, plasma or serum. Our first product, TR(ACE) assay, will monitor treatment response in oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raj Krishnan
Chief Financial Officer
Richard Slansky
VP - Operations
Iryna Clark
VP - Product Management
Robert Turner
VP - R & D
Juan Hinestrosa
VP - Regulatory Affairs
David Liu
Browse more venture capital transactions:
Prev: 11/9/2015: Genomind venture capital transaction
Next: 11/9/2015: SkySpecs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs